General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
JOHANNESBURG — South Africa has acquired 20 million doses of the Pfizer vaccine that are expected to arrive in the second quarter of the year, the government has confirmed.
The purchase is a significant boost to the government’s efforts to acquire vaccines to reach its goal of inoculating 40 million people, representing 67% of the country’s population, this year.
The cost of the Pfizer vaccines will be announced at a later date by Minister of Health Zweli Mkhize, said Lwazi Manzi, spokeswoman for the health ministry.
South Africa is eagerly awaiting the arrival Monday of its first delivery of vaccines, 1 million doses of the AstraZeneca vaccine from the Serum Institute of India. That will be followed up by another 500,000 doses later this month. Those AstraZeneca vaccines will be used to inoculate frontline health workers.
In the coming months, South Africa is expecting to receive 6 million vaccine doses from the international COVAX facility, 9 million of the Johnson & Johnson vaccine when it is approved, and an additional 20 million from the African Union’s vaccine acquisition task team.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.
On Monday, April 22, 2024, history was being written in a Manhattan courtroom.
PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.
PARIS (AP) — Paris has a new king of the crusty baguette.
WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.